Beyond the Breakthroughs Event, McMaster University
Held on April 16th at McMaster University, Beyond the Breakthroughs showcased NexusHealth which is a world-class initiative transforming how discoveries move from the lab to patients.
Through NexusHealth and the new Bioinnovation Building, researchers, clinicians and industry partners are accelerating health innovation in Canada.
The AeroVax Inhaled COVID vaccine was highlighted as an example of one of the discoveries being transformed from the lab to patients.
Dr. Smaill, the study’s principal investigator and Dr. Matt Miller, a co-investigator on the study participated in a panel discussion at the event which can be accessed here:
For a video overview of McMaster’s involvement with vaccinology research and development, please visit:
AeroVax NewsRelated News
News Listing
April 25, 2026
McMaster News ➚
Promising Results from the Phase 1 Study of the AeroVax Inhaled COVID Vaccine
AeroVax News
July 24, 2025
CTV News ➚
Creators of no-needle COVID-19 vaccine made in Hamilton seeking participants
AeroVax News
April 22, 2025
